Johnson & Johnson's (JNJ) results show the firm's ability to offset generic and branded competition, says Damien Conover. He and David Toung recap JNJ's earnings. They talk about how the 4Q international sales came in at $11.19B and 4Q worldwide consumer sales came in at $3.77B. They then go over the key takeaways from JNJ's earnings. Tune in to find out more about the stock market today.
25 Jan 2023
Market On Close
10 Nov 2022
Futures
24 Jan 2023
Trading 360
13 Jan 2023
Morning Trade Live
18 Jan 2023
Morning Trade Live
14 Nov 2022